|
Market Closed -
NYSE
00:00:03 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 95.29 USD | -0.09% |
|
-1.97% | +20.07% |
| 09-10 | CVS Health Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 09:30 AM | |
| 09-10 | TPG Explores $5 Billion Sale of Lyric | MT |
| Market Cap | 122B 105B 98.89B 90.09B 168B 11,652B 170B 1,178B 453B 5,910B 458B 448B 18,772B | P/E 2026 * |
13.9x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 174B 149B 141B 128B 240B 16,615B 242B 1,679B 646B 8,427B 653B 638B 26,767B | EV / Sales 2026 * |
0.42x | EV / Sales 2027 * | 0.4x |
| Free-Float |
71.17% | Yield 2026 * |
2.79% | Yield 2027 * | 2.87% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
CBOE
| CVS | Real-time | |
|
Xetra
| CVS | Delayed | |
|
London S.E.
| 0HRS | Delayed | |
|
Mexican S.E.
| CVS * | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Tradegate
| CVS | Real-time | |
|
Borsa Italiana
| 1CVS | End-of-day quote | |
|
Deutsche Boerse AG
| CVS | Delayed | |
|
Swiss Exchange
| CVS | Delayed | |
|
CBOE
| 0HRS | Real-time | |
|
Santiago S.E.
| CVSCL | End-of-day quote | |
|
Santiago S.E.
| CVS | End-of-day quote | |
|
Lima
| CVSUS | End-of-day quote | |
|
Boerse Muenchen
| CVS | Real-time | |
|
Wiener Boerse
| CVS | End-of-day quote | |
|
Börse Stuttgart
| CVS | Delayed | |
|
Swiss Exchange
| CVS | Delayed |
Last Transcript : CVS Health Corporation
| 1 day | -0.09% | ||
| 1 week | -1.97% | ||
| Current month | +1.47% | ||
| 1 month | -0.40% | ||
| 3 months | -2.79% | ||
| 6 months | +24.86% | ||
| Current year | +20.07% |
| 1 week | 92.79 |  | 97.98 |
| 1 month | 92.35 | | 98.5 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.51 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 17/10/2024 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 73 | 20/01/2011 |
| Director/Board Member | 71 | 05/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/05/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 31/05/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 21/05/26 | Glenview Capital Management LLC
| Sell | Company | -748,462 | 0.0584% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -1.97% | +28.82% | +44.73% | 122B | |
| -0.15% | +2.93% | +6.81% | +53.96% | 91.19B | |
| +0.15% | +1.09% | -5.41% | +58.47% | 29.28B | |
| -1.83% | -3.45% | +28.31% | +81.97% | 25.51B | |
| -0.13% | +1.09% | -2.23% | -4.40% | 21.69B | |
| -2.09% | -0.01% | +37.38% | +252.55% | 21.21B | |
| +3.06% | +1.79% | -2.66% | +34.73% | 16.28B | |
| -0.13% | -0.28% | -9.18% | -3.78% | 11.86B | |
| -0.92% | -0.18% | +37.10% | +89.77% | 11.56B | |
| 0.00% | +5.40% | -11.94% | +67.24% | 10.58B | |
| Average | -0.19% | +0.87% | +10.70% | +67.53% | 36.1B | |
| Weighted average by Cap. | -0.21% | +0.34% | +15.49% | +60.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 417B 359B 339B 308B 576B 39,885B 582B 4,032B 1,552B 20,231B 1,567B 1,532B 64,258B | 428B 369B 348B 317B 592B 40,967B 597B 4,141B 1,594B 20,779B 1,609B 1,574B 66,000B |
| Net income | 8.88B 7.63B 7.2B 6.56B 12.26B 849B 12.38B 85.77B 33.01B 430B 33.33B 32.6B 1,367B | 9.32B 8.01B 7.56B 6.89B 12.88B 891B 13B 90.06B 34.66B 452B 35B 34.23B 1,435B |
| Net Debt | 51.91B 44.64B 42.12B 38.37B 71.73B 4,963B 72.38B 502B 193B 2,517B 195B 191B 7,995B | 48.85B 42.01B 39.64B 36.11B 67.51B 4,671B 68.12B 472B 182B 2,369B 183B 179B 7,525B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $95.29 | -0.09% | 3,877,979 |
| 09/09/26 | $95.38 | -0.72% | 6,112,458 |
| 08/09/26 | $96.07 | -0.69% | 4,196,553 |
| 04/09/26 | $96.74 | -0.47% | 4,499,060 |
| 03/09/26 | $97.20 | -0.03% | 4,783,706 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
